Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oyster Point Pharma

11.17
+0.0000
Volume:- -
Turnover:23.31M
Market Cap:303.21M
PE:-1.68
High:11.17
Open:11.17
Low:11.17
Close:11.17
Loading ...
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 18, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 12, 2022

Major Issues Report

8-K - Current report
Jun 28, 2022

Major Issues Report

8-K - Current report
Jun 08, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 18, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 21, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 13, 2022

Major Issues Report

8-K - Current report
Jan 13, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 04, 2021

Major Issues Report

8-K - Current report
Nov 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 27, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership